About Us

We are a collective of ambitious undergraduate students at Baruch College who manage a portfolio of stocks spanning across a variety of sectors

Our History

2010
The Investment Management Group began with five students as a paper-money fund
2013
IMG received $250,000 to initiate the launch of a real-money, long-only equities portfolio
2020
IMG receives an additional $150,000 in funding, growing the total AUM to $540,000
2021
IMG posted double-digit returns, resulting in an additional $250,000 in funding
2022
The Baruch College Fund granted an additional $200,000, bringing us to over $1 million in AUM

Our Education Methods

The Investment Management Group's core philosophy is that education is a lifelong pursuit and that without proper education, our members will not be able to realize their full potential. 

A majority of a member's education is gained through hands-on experience, exposure to different teams, and self-initiative to explore beyond their knowledge horizon. Nevertheless, to properly equip each member for their role, our Development Team is charged with creating a comprehensive educational program. Headed by the Chief Development Officer, the Development Team holds training seminars, and homework assignments and provides suggested readings and other educational resources that cover a range of topics necessary for the professional success of our members.

At the beginning of every semester, we host educational seminars that highlight an introduction to the financial markets, fundamentals of financial statement analysis, comparative analysis, discounted cash flow analysis, and a primer on equity research. Advanced topics include Event-Driven Investing, Capital Markets, Mergers & Acquisitions, Leveraged Buyouts, and Restructuring. All new members are mandated to attend as it is a part of their core education.

Investment Coverage

Our Philosophy

We work to find companies that will be able to withstand and grow in any market condition. We believe our long-term approach of holding stocks for up to two years will provide us with the time needed for our stock picks to truly thrive. In our approach to investment decision-making, we ask questions at every step of the way. By considering all possibilities of performance, we believe we are optimally positioned for success. 

Investment Strategy

We use a combination of fundamental and technical analyses to evaluate investment ideas. Through our process, we perform both top-down and bottom-up analysis to narrow down macro-economic and micro-economic factors. We then employ our research to isolate idiosyncratic opportunities in all sectors. 

Consumer Goods & Retail

Food and Beverages, Agribusiness, Household and Personal Care Products, Restaurants, Tobacco, Apparel and Accessories, and Luxury Goods

Energy & Utilities

Oil, Gas, Nuclear, Wind, Solar, Biomass, Geothermal, Power Generation, Water, Electricity, Renewable Energy & Other

Financial Institutions Group (FIG)

Insurance, Mortgage Companies, Asset Managers, Bank and Finance Companies, Credit Card, Governments, Broker-Dealers, and Investment Firms

Healthcare

Healthcare Services, Pharmaceuticals, Biotechnology and Specialty Pharmaceuticals, Medical Devices, and Life-Science Tools

Industrials & Natural Resources

Metals & Mining, Timber, Manufacturing, Aerospace & Defense, and Housing & Construction

Technology, Media & Telecommunications (TMT)

Communication, Internet, Digital Media, Semiconductors, IT Services & Payments Processing, Software, Advertising & Marketing, Broadcasting, Entertainment, Wireless, and Telecom Operators

Meet our Leadership

Chief
Executive Officer

Simran Hassan

LinkedIn | simran.hassan@baruchimg.com

  • Simran is a junior in the Macaulay Honors Program, majoring in Finance & Investments and double minoring in English and New York City Studies. Simran joined IMG as an Analyst in her freshman year and covered the Technology, Media, and Telecommunications (TMT) sector as Analyst and Director. This summer, Simran will be interning at Deutsche Bank in the firm’s Investment Banking Division. Previously, she has interned at OK Capital, a Venture Capital Advisory firm, working directly with the CEO. In her free time, Simran enjoys baking, reading fiction, and playing word games. Simran will manage the day-to-day activities of IMG, alumni to firm engagement, and serve as the primary contact for the Baruch College Fund and Operating Committee.

Chief
Operating Officer

Ivan Sirotkin

LinkedIn | ivan.sirotkin@baruchimg.com

  • Ivan is a junior majoring in Finance & Investments and minoring in Political Science. Ivan joined IMG as a Junior Analyst covering TMT and later switched to the Financials Team where he served as the Director. This past summer, Ivan interned at Centerbridge Partners on the Insurance Solutions team, and previously interned at Wilton Re on the Investment Team. This upcoming summer, Ivan will be an Investment Banking Summer Analyst at Wells Fargo. Ivan is a Student-Athlete and runs for the Baruch Cross Country Team, and also enjoys hiking, lacrosse, and skiing. Ivan will oversee the club’s operational functions, marketing, and internal logistics, including recruitment initiatives.

Chief
Investment Officer

Chris John

LinkedIn | chris.john@baruchimg.com

  • Chris John is a junior majoring in Finance & Investments with a minor in Communications. He joined IMG in Fall 2022 as an Industrials & Natural Resources Analyst. In Fall 2023, Chris was promoted to Director of Energy & Utilities. In his free time, he enjoys attending live comedy shows. For Spring 2025, Chris will lead equity selection and allocation, position sizing, and risk management across the portfolio in collaboration with the Baruch College Fund (BCF) and the Portfolio Management (PM) team.

Chief
Development Officer

John Simon

LinkedIn | kaleo.simon@baruchimg.com

  • John is a Junior majoring in Financial Mathematics and minoring in New York City Studies as part of the Macaulay Honors Program at Baruch College. He joined IMG as an analyst where he covered Energy & Utilities as an Analyst and covered Financials as a Director. John will be joining the Bank of Montreal as an Investment Banking Summer Analyst. He also held internships at Jennison Associates and the Securities Industry & Financial Markets Association. In his free time, John enjoys playing the piano, cooking, and going to the gym. John will direct Saturday workshops covering the fundamentals of Accounting, Valuation, M&A, LBO, Event-Driven Investing, and Financial Restructuring.

Our Top Three Investment Holdings

United Therapeutics Corporation is a biotechnology company focused on developing treatments for chronic and life-threatening diseases. It offers therapies for pulmonary arterial hypertension (PAH), including Tyvaso DPI, Tyvaso, Remodulin, Orenitram, and Adcirca, as well as Unituxin for high-risk neuroblastoma. The company also provides innovative delivery systems like the Remunity Pump. The company is advancing research in gene therapy (Aurora-GT), xenografts (animal-based organ transplants), and treatments for idiopathic pulmonary fibrosis. It collaborates with partners like DEKA Research, MannKind Corporation, and Arena Pharmaceuticals on cutting-edge solutions. Founded in 1996, the company is headquartered in Silver Spring, Maryland.

Sub-Industry: Biotechnology

Apollo Global Management, Inc. is a private equity firm specializing in investments across credit, private equity, infrastructure, real estate, and secondaries. Its strategies include traditional buyouts, distressed investments, recapitalizations, and growth capital, as well as credit investments like direct lending, structured credit, and mezzanine debt. The firm serves institutional and individual investors, managing portfolios, hedge funds, real estate funds, and private equity funds. Apollo invests globally across industries such as energy, technology, telecom, financial services, and sustainable solutions like clean energy and climate initiatives. Founded in 1990, it is headquartered in New York, New York, with offices worldwide.

Sub-Industry: Diversified Financial Services

Neurocrine Biosciences, Inc. is a pharmaceutical company focused on developing and marketing treatments for neurological, neuroendocrine, and neuropsychiatric disorders. Its key products include INGREZZA for tardive dyskinesia and Huntington’s chorea, ALKINDI and Efmody for adrenal insufficiency, Orilissa for endometriosis, and Oriahnn for uterine fibroids. The company is advancing a pipeline of therapies for conditions such as dyskinetic cerebral palsy, epilepsy, schizophrenia, movement disorders, and major depressive disorder. Neurocrine collaborates with partners like Takeda, AbbVie, and Xenon Pharmaceuticals to develop innovative treatments. Founded in 1992, it is headquartered in San Diego, California.

Sub-Industry: Biotechnology